4 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 35099526 | Corrigendum to: CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz. | 2022 Mar 1 | 1 |
| 2 | 32667979 | Implications of Efavirenz Pharmacogenetics When Switching From Efavirenz- to Dolutegravir-containing Antiretroviral Regimens. | 2021 May 18 | 1 |
| 3 | 32960272 | CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz. | 2021 Dec 6 | 1 |
| 4 | 34328253 | In vitro assessment of the potential for dolutegravir to affect hepatic clearance of levonorgestrel. | 2021 Nov | 2 |